Mycobacterium Tuberculosis Testing Market To Grow at 4% CAGR

The market for mycobacterium tuberculosis tests in India is expected to grow at a compound annual growth rate of 4% between 2023 and 2033 as the country works to combat tuberculosis, a persistent global health challenge that continues to affect countries worldwide, including India. According to GlobalData's report on 'Mycobacterium Tuberculosis Tests Market Size By Segments, Share, Regulatory And Reimbursement, Procedures, And Forecast To 2033,' India will have the highest incidence of mycobacterium tuberculosis cases in the Asia-Pacific (APAC) region in 2023.

The 'India Fights' TB program, headed by the HEAL Foundation and Mylan Pharmaceuticals Private Limited, is implementing a comprehensive approach to address the ongoing tuberculosis concerns. It prioritizes reducing social stigma and improving treatment adherence above medical breakthroughs. This comprehensive strategy, focusing on public education and the creation of a supportive environment, is consistent with the overriding goal of not only treating TB but also encouraging patients to successfully finish their treatment. Rachna Tripathi, Medical Devices Analyst at GlobalData, said, “The launch of the ‘India Fights TB’ initiative is commendable in the ongoing battle against tuberculosis in India.

With a staggering 2.64 million reported cases in 2022, tuberculosis remains a formidable public health challenge". "Initiatives like this one are not just important but also reflect the collective commitment to spreading awareness, reducing the stigma surrounding the disease, and ensuring that individuals receive timely diagnosis and treatment,” said Tripathi. One striking aspect of India's TB management strategy is its patient-centric approach. This shift may drive the creation of user-friendly and accessible medical devices for TB diagnosis, monitoring, and treatment adherence, as per pharmabiz.